Similar articles for PMID: 29152087

Year	Number of Results
2000	1
2002	1
2003	1
2004	4
2005	3
2006	7
2007	5
2008	2
2009	2
2010	5
2011	9
2012	5
2013	3
2014	3
2015	6
2016	4
2017	5
2018	3
2019	3
2020	1
2021	8
2022	2
2024	0

1

Specific role of RhoC in tumor invasion and metastasis.

Lang S, Busch H, Boerries M, Brummer T, Timme S, Lassmann S, Aktories K, Schmidt G. Lang S, et al. Oncotarget. 2017 Sep 16;8(50):87364-87378. doi: 10.18632/oncotarget.20957. eCollection 2017 Oct 20. Oncotarget. 2017. PMID: 29152087 Free PMC article.

2

Characterization of the roles of RHOC and RHOA GTPases in invasion, motility, and matrix adhesion in inflammatory and aggressive breast cancers.

Wu M, Wu ZF, Rosenthal DT, Rhee EM, Merajver SD. Wu M, et al. Cancer. 2010 Jun 1;116(11 Suppl):2768-82. doi: 10.1002/cncr.25181. Cancer. 2010. PMID: 20503409 Free article.

3

Up-regulation of small GTPases, RhoA and RhoC, is associated with tumor progression in ovarian carcinoma.

Horiuchi A, Imai T, Wang C, Ohira S, Feng Y, Nikaido T, Konishi I. Horiuchi A, et al. Lab Invest. 2003 Jun;83(6):861-70. doi: 10.1097/01.lab.0000073128.16098.31. Lab Invest. 2003. PMID: 12808121 Free article.

4

Formin-like 2 drives amoeboid invasive cell motility downstream of RhoC.

Kitzing TM, Wang Y, Pertz O, Copeland JW, Grosse R. Kitzing TM, et al. Oncogene. 2010 Apr 22;29(16):2441-8. doi: 10.1038/onc.2009.515. Epub 2010 Jan 25. Oncogene. 2010. PMID: 20101212

5

RhoA and RhoC proteins promote both cell proliferation and cell invasion of human oesophageal squamous cell carcinoma cell lines in vitro and in vivo.

Faried A, Faried LS, Kimura H, Nakajima M, Sohda M, Miyazaki T, Kato H, Usman N, Kuwano H. Faried A, et al. Eur J Cancer. 2006 Jul;42(10):1455-65. doi: 10.1016/j.ejca.2006.02.012. Epub 2006 Jun 5. Eur J Cancer. 2006. PMID: 16750623

6

Functional analysis of the contribution of RhoA and RhoC GTPases to invasive breast carcinoma.

Simpson KJ, Dugan AS, Mercurio AM. Simpson KJ, et al. Cancer Res. 2004 Dec 1;64(23):8694-701. doi: 10.1158/0008-5472.CAN-04-2247. Cancer Res. 2004. PMID: 15574779

7

"Smart" Nanoparticles Enhance the Cytoplasmic Delivery of Anti-RhoC Silencing RNA and Inhibit the Migration and Invasion of Aggressive Breast Cancer Cells.

Kaushal N, Durmaz YY, Bao L, Merajver SD, ElSayed ME. Kaushal N, et al. Mol Pharm. 2015 Jul 6;12(7):2406-17. doi: 10.1021/acs.molpharmaceut.5b00114. Epub 2015 May 28. Mol Pharm. 2015. PMID: 26020100

8

Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma.

Faried A, Faried LS, Usman N, Kato H, Kuwano H. Faried A, et al. Ann Surg Oncol. 2007 Dec;14(12):3593-601. doi: 10.1245/s10434-007-9562-x. Epub 2007 Sep 25. Ann Surg Oncol. 2007. PMID: 17896152

9

Anti-RhoA and anti-RhoC siRNAs inhibit the proliferation and invasiveness of MDA-MB-231 breast cancer cells in vitro and in vivo.

Pillé JY, Denoyelle C, Varet J, Bertrand JR, Soria J, Opolon P, Lu H, Pritchard LL, Vannier JP, Malvy C, Soria C, Li H. Pillé JY, et al. Mol Ther. 2005 Feb;11(2):267-74. doi: 10.1016/j.ymthe.2004.08.029. Mol Ther. 2005. PMID: 15668138 Free article.

10

Farnesyl transferase inhibitor treatment of breast cancer cells leads to altered RhoA and RhoC GTPase activity and induces a dormant phenotype.

Chatterjee M, van Golen KL. Chatterjee M, et al. Int J Cancer. 2011 Jul 1;129(1):61-9. doi: 10.1002/ijc.25655. Epub 2010 Oct 26. Int J Cancer. 2011. PMID: 20824700 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year